≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Dysplastic lesion of unknown severity of the cervix uteri

Endpoint Browser PheWeb

N14_CERVICAL_DYSPLASIA_NOS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — N87.9
  • Cause of death: ICD-10 — N87.9

2 out of 7 registries used, show all original rules.

373

4. Check minimum number of events

None

373

5. Include endpoints

None

373

6. Filter based on genotype QC (FinnGen only)

373

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2302 2302 -
Only index persons 2267 2267 -
Unadjusted period prevalence (%)
Whole population 0.07 0.07 -
Only index persons 0.08 0.08 -
Median age at first event (years)
Whole population - 39.51 -
Only index persons - 39.34 -

-FinnGen-

Key figures

All Female Male
Number of individuals 373 373 -
Unadjusted period prevalence (%) 0.13 0.13 -
Median age at first event (years) 40.11 40.11 -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
339
Matched controls
3389
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N87.9
ICD-10 Finland
Dysplasia of cervix uteri, unspecified
+∞
323.0
339
*
ULA02
NOMESCO Finland
Kolposcopy
22.1
134.0
242
344
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
17.6
106.1
192
234
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
20.0
94.8
154
135
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
13.3
94.3
203
342
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
10.1
77.0
194
397
LDA10
NOMESCO Finland
Curettage of cervix uteri
12.8
59.7
115
131
N87.0
ICD-10 Finland
Mild cervical dysplasia
14.7
42.7
74
63
N87.2
ICD-10 Finland
Severe cervical dysplasia, not elsewhere classified
13.9
42.6
76
69
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
12.7
30.7
56
52
N87.1
ICD-10 Finland
Moderate cervical dysplasia
9.6
26.1
55
67
A63.0
ICD-10 Finland
Anogenital (venereal) warts
5.8
15.7
46
90
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.1
9.9
180
1186
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
24.8
9.0
12
5
8140/2-C53.9
ICD-O-3
Adenocarcinoma in situ, NOS, of cervix uteri
92.3
8.5
9
*
LEB00
NOMESCO Finland
Biopsy of vagina
6.6
7.8
19
30
R87.5
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal microbiological findings
9.7
7.4
14
15
X86
ICPC
Abnormal cervix smear
7.6
7.3
16
22
R87.9
ICD-10 Finland
Abnormal findings in specimens from female genital organs, unspecified abnormal finding
17.1
6.8
10
6
LDB20
NOMESCO Finland
Electrocoagulation or laser therapy of cervix uteri
7.6
6.5
14
19
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
5.4
6.4
18
35
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
27.2
6.3
8
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
118
226
7.17
63.31
2.2
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
76
106
8.75
53.80
2.4
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
199
1066
2.86
22.03
2.5
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
17
63
2.78
3.54
1.8
2.0
%
13.1
13.3
0.37
17
63
(3019150) Specific gravity of Urine by Refractometry
95
670
1.56
3.30
3.2
3.2
kg/l
1.0
1.0
0.97
16
87
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
13
304
0.41
2.74
1.7
3.4
%
24.6
33.3
—
5
215
(3029937) Albumin [Presence] in Urine by Test strip
109
822
1.46
2.70
3.2
3.3
estimate
0.0
0.0
1.08
38
311
(3019225) pH of Specimen
9
229
0.38
2.64
2.8
3.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
153
1236
1.40
2.58
3.1
3.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
157
0.31
2.33
1.4
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
35
2.91
2.32
1.7
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
186
1574
1.36
2.29
3.2
3.1
estimate
0.0
0.0
0.00
38
304
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
272
2955
0.71
2.24
8.5
8.8
ml/min/173m2
92.3
90.5
0.75
203
2359
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
112
876
1.40
2.23
2.7
2.2
u/l
54.6
55.5
0.12
105
815
(3001019) Free T4 and TSH panel - Serum or Plasma
19
353
0.51
2.17
2.3
1.8
—
—
—
0
0
(4010399)
31
186
1.73
2.05
1.6
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
51
2.40
1.97
1.0
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
186
1599
1.33
1.96
3.2
3.1
estimate
0.0
0.0
0.50
38
302
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
85
2.05
1.93
4.4
9.1
—
—
—
0
0
(3013512) EKG study
46
654
0.66
1.87
2.0
2.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
181
0.43
1.87
1.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
193
0.45
1.78
1.2
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
193
0.45
1.78
1.2
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
193
0.45
1.78
1.2
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
194
0.45
1.78
1.2
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
36
236
1.58
1.73
3.4
2.4
e9/l
4.4
4.0
0.32
36
197
(3021601) Nitrite [Presence] in Urine by Test strip
182
1581
1.30
1.70
4.2
4.3
estimate
0.0
0.0
0.50
38
314
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
14
3.60
1.62
1.2
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
712
0.70
1.60
1.7
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
85
671
1.35
1.57
1.2
1.3
iu/ml
18.8
29.2
0.88
34
236
(4035726)
34
227
1.55
1.53
1.4
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
27
2.62
1.52
2.1
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
21
2.89
1.51
2.0
2.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
263
0.55
1.46
1.6
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
22
133
1.70
1.46
2.0
2.4
ug/l
1.8
4.1
2.40
22
118
(3002032) Base excess in Venous blood by calculation
26
165
1.62
1.44
4.0
3.1
mmol/l
2.1
2.3
0.16
21
132
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
262
0.55
1.44
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
262
0.55
1.44
1.6
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
39
2.34
1.44
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
261
0.56
1.42
1.6
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
46
2.21
1.41
7.0
1.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
21
127
1.69
1.40
1.1
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
29
2.44
1.40
1.3
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
159
1.61
1.38
1.8
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
0
38
0.00
1.35
0.0
2.5
—
1.4
—
0
28
(40768804) Tissue Pathology biopsy report
163
1427
1.25
1.34
2.6
2.0
—
—
—
0
0
(3012544) pH of Venous blood
26
169
1.58
1.33
4.0
3.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
6
24
2.52
1.31
3.8
2.1
e6/l
515.7
505.9
—
6
19
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
17
278
0.59
1.30
1.6
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
124
1055
1.26
1.30
4.2
4.0
g/l
36.4
36.8
0.41
118
989
(3037522) Nuclear Ab [Titer] in Serum
66
520
1.33
1.24
1.4
1.4
titre
707.5
507.1
0.25
16
112
(3013707) Erythrocyte sedimentation rate by Westergren method
251
2319
1.25
1.23
3.7
3.8
mm/h
9.8
9.5
0.18
237
2167
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
239
1.46
1.23
1.6
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
122
1044
1.25
1.21
4.7
2.9
u/l
34.0
27.8
0.63
116
1005
(3044889) 12 lead EKG panel
216
1967
1.23
1.20
3.2
2.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
50
2.03
1.17
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
49
373
1.36
1.16
1.2
1.2
iu/ml
122.8
165.3
0.38
27
168
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
82
675
1.28
1.12
1.2
1.3
u/ml
13.2
14.9
0.06
28
279
(3003694) ABO and Rh group [Type] in Blood
92
1087
0.80
1.11
1.8
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
66
1.85
1.10
1.5
1.5
g/l
3.1
3.0
0.10
12
56
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
42
315
1.38
1.09
2.1
2.3
umol/l
5.9
5.5
0.18
31
268
(3009508) Creatinine [Moles/volume] in Urine
57
713
0.76
1.09
3.7
2.8
mmol/l
7.1
7.7
0.52
51
609
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
88
734
1.26
1.08
1.6
1.7
mg/l
0.7
0.8
0.25
67
550
(3018418) pH of Serum or Plasma
92
773
1.25
1.06
4.6
3.4
ph
7.4
7.4
—
7
141
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
89
747
1.25
1.04
2.0
2.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
34
2.08
1.03
2.0
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
83
1.71
1.03
1.1
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
108
0.46
1.02
1.0
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
142
1256
1.21
1.01
5.3
5.3
mmol/l
1.2
1.2
0.29
124
1066
(3019230) Fractional oxyhemoglobin in Venous blood
5
23
2.19
0.98
1.8
2.0
%
62.4
60.4
—
5
23
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
39
295
1.36
0.97
1.8
2.1
u/l
1578.5
3993.1
0.85
11
129
(3004789) Transferrin [Mass/volume] in Serum or Plasma
45
350
1.32
0.94
2.4
2.1
g/l
2.5
2.5
0.33
39
326
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
241
2248
1.20
0.94
6.8
6.4
u/l
73.3
73.5
0.03
227
2113
(40761535) Cells panel - Urine sediment
28
201
1.42
0.94
3.5
2.9
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
70
1.74
0.93
1.5
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
70
1.74
0.93
1.5
1.4
g/l
7.5
7.3
0.11
12
58
(3044640) Blood type and Crossmatch panel - Blood
81
953
0.81
0.93
1.8
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
81
685
1.23
0.89
3.5
3.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
47
372
1.30
0.88
1.5
1.6
—
—
—
0
0
(1002224) Polysomnography panel
10
166
0.59
0.85
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
39
496
0.76
0.85
1.2
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
102
887
1.21
0.85
2.5
2.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
25
180
1.42
0.84
1.8
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
114
0.52
0.84
1.0
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
17
113
1.53
0.83
1.4
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
65
1.71
0.83
1.5
1.5
g/l
10.6
9.9
0.33
11
60
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
159
1444
1.18
0.81
5.0
5.3
umol/l
10.2
9.3
0.65
148
1362
(3000991) Gas panel - Venous blood
20
139
1.46
0.81
6.1
7.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
222
0.66
0.80
1.7
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
31
237
1.34
0.75
1.5
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
63
530
1.23
0.73
1.6
1.5
pmol/l
436.0
43162830.0
1.05
55
468
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
108
0.55
0.73
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
(3015736) pH of Urine
136
1229
1.17
0.72
3.2
2.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
28
212
1.35
0.72
1.6
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
98
862
1.19
0.72
4.7
5.4
inr
1.0
1.1
2.20
31
288
(3047352) Trisomy 18 risk [Likelihood] in Fetus
15
216
0.68
0.71
1.6
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
15
214
0.69
0.68
1.6
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
107
954
1.17
0.67
2.5
2.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
38
307
1.26
0.64
2.8
2.3
%
26.8
22.8
0.93
30
258
(3048689) Calprotectin [Mass/mass] in Stool
56
473
1.22
0.64
2.4
2.1
ug/g
68.1
96.1
0.62
42
364
(3041354) Potassium [Moles/volume] in Venous blood
5
29
1.73
0.64
1.4
2.5
mmol/l
4.1
4.0
—
5
29
(44813793)
5
29
1.73
0.64
1.6
1.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
29
1.73
0.64
1.4
2.5
mmol/l
104.0
106.0
—
5
29
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
29
1.73
0.64
1.4
2.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
29
1.73
0.64
1.0
1.1
u/l
14.8
16.7
—
5
23
(3007164) IgA [Mass/volume] in Serum or Plasma
66
763
0.84
0.64
1.5
1.4
g/l
2.7
2.2
1.48
46
491
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
235
1.30
0.63
1.5
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
56
656
0.83
0.62
2.2
2.1
umol/l
303.0
5497.6
2.75
48
598
(1761482) Bacteria [#/volume] in Urine by Culture
8
49
1.65
0.62
3.1
4.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
49
410
1.22
0.61
2.9
3.1
ng/l
183.6
170.8
0.03
29
231
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
30
1.68
0.61
1.2
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
5
30
1.68
0.61
1.2
1.1
—
1.1
—
0
13
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
21
0.00
0.60
0.0
1.6
—
43.9
—
0
16
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
21
0.00
0.60
0.0
2.9
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
0
22
0.00
0.59
0.0
1.4
—
53.5
—
0
11
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
22
0.00
0.59
0.0
1.1
—
120.4
—
0
16
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
36
1.68
0.57
1.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
73
1.52
0.57
1.7
2.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
21
159
1.34
0.56
1.3
1.3
u/ml
2.5
1.2
—
5
9
(3028707) Methadone [Presence] in Urine by Screen method
5
89
0.56
0.56
1.4
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
102
919
1.15
0.56
1.9
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
38
1.59
0.54
1.5
1.9
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
6
38
1.59
0.54
1.8
4.7
mg/l
40.3
19.8
—
6
30
(3034860) Kappa light chains.free [Mass/volume] in Serum
6
38
1.59
0.54
1.7
4.7
mg/l
62.2
30.8
—
6
31
(3020961) Endomysium IgA Ab [Titer] in Serum
25
196
1.30
0.54
1.1
1.1
—
195.0
—
0
6
(4034850)
6
98
0.61
0.52
14.8
5.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
40
1.51
0.52
1.2
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
13
92
1.43
0.51
1.5
2.3
%
1.4
1.1
0.40
13
92
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
20
154
1.32
0.49
1.6
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
107
0.65
0.49
1.4
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
107
0.65
0.49
1.4
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
110
0.63
0.49
1.4
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
36
302
1.21
0.46
1.9
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
61
686
0.87
0.44
1.7
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
14
104
1.36
0.43
5.2
4.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
41
351
1.19
0.43
1.7
1.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
10
70
1.44
0.42
1.1
1.1
—
12.6
—
0
8
(3018095) Leukocytes [#/volume] in Urine
92
1003
0.89
0.41
4.2
3.0
e6/l
74.3
59.4
0.17
65
642
(4281824)
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
130
1390
0.90
0.41
7.7
7.4
e9/l
0.0
0.0
0.99
112
1142
(3042936) Bacteria identified in Isolate by Culture
41
353
1.18
0.41
1.7
2.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
15
0.00
0.41
0.0
2.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
292
0.81
0.41
1.1
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
357
3607
0.76
0.41
15.9
15.7
e9/l
6.8
6.6
0.50
350
3527
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
132
1.30
0.41
1.5
1.5
—
—
—
0
0
(3016750) Collection duration of Urine
0
17
0.00
0.40
0.0
2.4
—
517.9
—
0
11
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
94
1022
0.89
0.40
1.6
1.7
pmol/l
95.5
98.9
0.30
53
547
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
60
1.34
0.40
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
34
1.48
0.40
1.2
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
18
0.00
0.40
0.0
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
27.0
—
0
18
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
71
1.42
0.39
1.3
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
160
1.26
0.39
1.5
2.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
357
3606
0.77
0.39
15.9
15.7
e12/l
4.4
4.4
0.75
351
3532
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
292
2844
1.12
0.38
13.7
12.6
%
13.4
13.5
1.02
286
2805
(36660697) Celiac disease serology panel - Serum
26
311
0.82
0.38
1.0
1.2
—
—
—
0
0
(4062490)
5
36
1.39
0.38
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
33
281
1.19
0.38
3.2
3.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
264
2718
0.90
0.37
4.8
4.4
mmol/mol
37.6
37.9
0.28
249
2576
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
15
191
0.78
0.37
1.1
1.8
mg/l
3.2
2.5
—
10
125
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
21
256
0.81
0.37
5.0
2.2
u/l
40.9
32.1
0.51
16
217
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
37
1.36
0.37
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
72
1.40
0.37
1.8
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
11
81
1.37
0.36
7.6
2.9
mmol/l
24.1
24.2
0.07
11
76
(4268621)
6
41
1.47
0.36
1.8
2.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
122
0.73
0.36
1.1
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
39
444
0.86
0.34
2.2
2.3
mmol/l
2.4
2.4
1.18
34
394
(3000330) Specific gravity of Urine by Test strip
16
127
1.27
0.34
3.1
2.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
341
3360
1.17
0.34
8.7
8.5
u/l
25.4
23.7
0.33
331
3274
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
280
2729
1.10
0.33
4.2
4.5
pmol/l
14.3
14.3
0.07
265
2570
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
305
3110
0.89
0.33
3.5
3.6
mmol/l
4.8
4.9
0.26
295
2960
(3002582) Erythrocytes [#/volume] in Urine
72
784
0.90
0.32
4.0
2.6
e6/l
22.2
67.6
1.25
56
580
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
54
486
1.13
0.32
1.7
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
38
334
1.15
0.31
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
56
507
1.12
0.30
1.9
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
102
1.28
0.30
1.1
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
169
1762
0.93
0.29
2.9
2.8
ug/l
71.9
63.1
0.46
164
1674
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
45
403
1.13
0.29
3.7
2.1
e6/l
0.8
0.9
0.10
32
213
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
8
106
0.75
0.29
1.8
1.6
%
94.0
95.5
—
8
98
(3007853) Bacteria identified in Skin by Aerobe culture
37
327
1.15
0.29
1.4
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
62
1.30
0.28
1.3
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
88
940
0.92
0.27
4.0
2.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
65
1.24
0.27
1.5
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
43
388
1.12
0.25
1.7
1.6
nmol/l
1248.2
1208.0
0.13
38
304
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
309
3139
0.91
0.25
3.8
3.9
mmol/l
2.9
2.9
0.22
290
2970
(3014051) Protein [Presence] in Urine by Test strip
9
74
1.22
0.25
1.6
1.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
82
767
1.09
0.25
1.7
1.7
mmol/l
1.3
1.4
0.11
73
674
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
6
81
0.74
0.24
1.2
1.5
mmol/l
3.2
3.6
—
6
72
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
106
1.23
0.23
1.3
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
38
1.32
0.23
1.6
1.7
u/ml
2.5
3.5
—
5
30
(3021788) Differential panel - Synovial fluid
5
38
1.32
0.23
1.2
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
57
616
0.91
0.23
4.4
3.8
mg/mmol
9.7
7.5
0.18
38
373
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
19
221
0.85
0.23
2.8
2.1
ml/min/173m2
85.2
80.6
—
5
90
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
39
1.29
0.23
1.0
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
148
1422
1.07
0.23
5.9
5.3
%
0.7
0.7
0.06
138
1317
(3013115) Eosinophils [#/volume] in Blood
171
1651
1.07
0.23
5.5
5.7
e9/l
0.2
0.2
0.34
162
1477
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
305
3096
0.92
0.23
3.5
3.6
mmol/l
1.5
1.6
0.99
289
2938
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
92
0.76
0.22
2.4
1.8
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
40
1.25
0.22
2.8
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
225
2193
1.07
0.22
3.9
3.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
3.3
—
—
—
0
0
(3000012) Reticulocyte production index
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.3
—
1.5
—
0
11
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
3.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
43.4
—
0
12
(3030467) Casts [#/volume] in Urine by Automated count
67
715
0.92
0.21
4.4
2.4
e6/l
0.4
0.4
0.03
52
519
(40765089) Chromosome analysis panel - Blood by G-banded
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.8
—
329.0
—
0
13
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
25
221
1.14
0.20
1.7
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
23
202
1.15
0.20
1.9
2.8
%
1.8
1.8
0.00
23
179
(4146454)
0
14
0.00
0.20
0.0
2.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
30.9
—
0
14
(3013139) Helicobacter pylori Ag [Presence] in Stool
26
231
1.13
0.20
1.2
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
50
1.20
0.20
1.5
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
41
446
0.91
0.19
1.6
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
6
51
1.18
0.19
1.5
1.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
53
569
0.92
0.19
1.4
1.4
nmol/l
25.2
22.1
0.82
45
495
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
227
0.87
0.18
1.1
1.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
25
223
1.13
0.18
4.9
5.7
mmol/l
104.2
104.3
0.03
25
216
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
67
710
0.93
0.18
2.1
2.0
mg/l
2.6
2.7
0.24
60
612
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
60
1.17
0.18
1.3
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
23
257
0.89
0.17
1.9
2.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
23
205
1.13
0.17
3.3
4.2
ug/l
22.4
7.7
0.50
15
163
(3004716) Salmonella sp identified in Stool by Organism specific culture
21
236
0.88
0.17
2.1
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
63
1.11
0.17
1.9
3.2
e9/l
4.0
4.5
—
7
63
(3003327) Ova and parasites identified in Stool by Light microscopy
12
141
0.85
0.16
1.4
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
70
1.15
0.16
1.1
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
308
3114
0.94
0.15
4.8
5.1
mu/l
1.7
2.1
0.55
291
2955
(42870588) Differential panel, method unspecified - Blood
93
968
0.95
0.15
5.6
5.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
22
198
1.12
0.14
1.7
2.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
198
1.12
0.14
1.1
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
95
913
1.05
0.14
2.3
2.8
ng/l
112.6
17.5
0.51
35
428
(46235355) HIV 1 and 2 tests - Meaningful Use set
97
1006
0.95
0.13
2.1
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
80
834
0.95
0.13
3.0
4.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
127
1308
0.96
0.13
2.2
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
158
1541
1.04
0.13
3.9
3.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
149
1527
0.96
0.12
5.5
5.1
%
55.0
56.5
0.92
140
1429
(3006315) Basophils [#/volume] in Blood
155
1586
0.96
0.12
5.3
5.3
e9/l
0.0
0.0
0.73
140
1392
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
404
0.93
0.11
1.3
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
70
729
0.95
0.11
4.2
2.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
177
1804
0.96
0.11
7.6
8.4
e9/l
4.0
3.9
0.20
163
1589
(3012516) Albumin [Mass/volume] in Urine
57
594
0.95
0.10
3.8
3.1
mg/l
60.0
286.5
0.70
39
368
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
155
1580
0.97
0.09
5.3
5.3
e9/l
0.5
0.5
0.25
142
1391
(3009542) Hematocrit [Volume Fraction] of Blood
311
3087
1.04
0.09
12.9
11.3
%
39.5
39.6
0.10
249
2545
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
54
1.11
0.09
2.2
2.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
54
1.11
0.09
1.2
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
1.2
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
16
175
0.91
0.08
1.3
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
113
1104
1.03
0.08
5.3
4.7
mmol/l
1.2
1.2
0.17
104
1018
(3014007) Fractional oxyhemoglobin in Arterial blood
12
107
1.13
0.08
6.2
7.7
%
90.4
94.4
0.64
12
107
(3000494) Fungus identified in Specimen by Culture
32
338
0.94
0.08
1.3
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
60
0.83
0.08
1.4
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
64
0.78
0.08
1.2
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
65
0.77
0.08
1.0
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
64
1.10
0.08
1.9
3.8
%
59.1
58.9
—
7
64
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
123
0.89
0.08
2.2
2.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
67
1.05
0.08
1.1
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
70
0.85
0.07
1.0
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
37
387
0.95
0.07
1.1
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
80
780
1.03
0.07
6.0
6.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
95
0.84
0.06
2.3
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
18
193
0.93
0.06
1.9
1.3
miu/ml
266.1
253.5
—
9
101
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
9
103
0.87
0.06
1.0
1.5
u/l
17.3
22.9
—
9
87
(3023103) Potassium [Moles/volume] in Serum or Plasma
310
3118
0.97
0.06
10.9
10.2
mmol/l
3.9
3.9
0.19
302
3016
(3045414) Leukocytes [Presence] in Urine
16
148
1.08
0.06
1.4
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
69
672
1.03
0.06
1.9
1.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
309
3107
0.97
0.06
10.9
10.1
mmol/l
139.4
139.6
0.83
301
3017
(3000850) Epithelial cells [#/volume] in Urine
56
544
1.03
0.05
3.2
2.3
e6/l
11.6
9.6
0.17
43
473
(3002030) Lymphocytes/100 leukocytes in Blood
152
1540
0.98
0.05
5.6
5.3
%
31.0
29.7
0.94
144
1434
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
49
475
1.04
0.05
1.7
2.8
ng/l
313.6
653.0
2.14
34
390
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
131
1327
0.98
0.04
2.2
2.2
nmol/l
74.9
75.4
0.06
121
1227
(3000492) Spirometry study
31
298
1.04
0.04
1.7
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
50
487
1.03
0.04
2.0
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
39
378
1.04
0.04
3.5
2.2
e6/l
3.9
4.4
0.13
26
188
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
121
1.08
0.04
1.3
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
340
3411
0.96
0.03
10.3
9.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
150
1485
1.02
0.03
6.0
5.4
%
8.2
7.9
0.47
141
1390
(3013826) Glucose [Moles/volume] in Serum or Plasma
161
1595
1.02
0.03
3.6
3.8
mmol/l
6.3
6.3
0.01
144
1435
(3019198) Lymphocytes [#/volume] in Blood
162
1635
0.98
0.03
5.6
5.3
e9/l
2.0
2.0
0.27
151
1465
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
53
518
1.03
0.03
1.5
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
322
3208
1.03
0.03
10.9
10.3
mg/l
22.6
18.5
1.17
246
2431
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
25
240
1.04
0.03
1.2
1.2
—
21.5
—
0
8
(3026782) Osmolality of Urine
51
499
1.03
0.03
3.3
2.3
mosm/kgh2o
523.2
536.3
0.17
40
419
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
122
1.07
0.02
2.7
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
55
559
0.98
0.02
3.5
3.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
31
302
1.03
0.02
1.7
2.0
nmol/l
378.6
373.6
0.05
31
284
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
296
2968
0.99
0.01
3.0
3.3
mmol/l
1.2
1.2
0.29
280
2808
(3006504) Eosinophils/100 leukocytes in Blood
149
1482
1.01
0.01
5.5
5.2
%
2.9
2.7
0.66
139
1378
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
86
853
1.01
0.01
1.9
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
42
414
1.02
0.00
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
298
2986
0.99
0.00
3.4
3.6
mmol/l
5.6
5.6
0.08
277
2797
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
227
2276
0.99
0.00
2.8
2.8
u/l
41.8
33.6
0.80
217
2183
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
109
1.01
0.00
1.7
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
22
221
1.00
0.00
9.0
12.1
—
1.2
—
0
36
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
89
889
1.00
0.00
1.2
1.3
u/ml
0.7
2.1
1.53
25
257
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
143
0.98
0.00
1.8
1.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
15
153
0.98
0.00
10.1
6.8
mmol/l
9.4
7.2
0.52
15
146
(3050129) First trimester maternal screen panel - Serum or Plasma
30
297
1.01
0.00
1.4
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
21
205
1.03
0.00
1.3
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
305
1.02
0.00
7.1
4.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
265
2645
1.01
0.00
3.6
3.9
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
9
0.00
0.00
0.0
3.3
—
45.8
—
0
9
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.7
—
132.8
—
0
9
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3032057) Clostridioides difficile [Presence] in Stool
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
3.7
—
0
6
(3034988) Calcium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
2.0
—
1.2
—
0
7
(3043409) Potassium [Moles/volume] in Arterial blood
5
59
0.85
0.00
8.0
3.5
mmol/l
3.4
3.7
—
5
51
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
59
0.85
0.00
1.4
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
8
0.00
0.00
0.0
1.1
—
145.4
—
0
8
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
11.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3035880) pH of Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
7
0.00
0.00
0.0
1.1
—
441.4
—
0
7
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
15.9
—
0
5
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4306422)
6
61
0.98
0.00
2.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
8
0.00
0.00
0.0
8.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
17
170
1.00
0.00
4.2
5.5
mmol/l
1.2
1.2
0.07
17
165
(3020891) Body temperature
6
69
0.87
0.00
7.3
4.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
66
0.91
0.00
15.0
3.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
76
0.92
0.00
1.1
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
41.1
—
0
6
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
2.0
—
1.2
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint N14_CERVICAL_DYSPLASIA_NOS and mortality.

Females

Parameter HR [95% CI] p-value
N14_CERVICAL_DYSPLASIA_NOS 1.369 [1.07, 1.75] 0.012
Birth year 0.993 [0.98, 1.0] 0.115

During the follow-up period (1.1.1998 — 31.12.2019), 106 out of 1959 females with N14_CERVICAL_DYSPLASIA_NOS died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_CERVICAL_DYSPLASIA_NOS.

N-year risk Females Males
1 0.13% No data
5 0.761% No data
10 1.873% No data
15 3.773% No data
20 6.533% No data

Relationships between endpoints

↥

Index endpoint: N14_CERVICAL_DYSPLASIA_NOS – Dysplastic lesion of unknown severity of the cervix uteri

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data